Home / Share Price Target / Ttfl
Trident Texofab Share Price Target 2024, 2025, 2026 to 2039 With Charts
Trident Texofab Limited | |||
 | Symbol: TTFL | ||
| Price: ₹107.15 | |||
| Exchange: BSE | |||
| -> | |||
Show Table of Contents
Table of Contents
- 0.1: Trident Texofab Financial Performance
- 0.1.1: Is Trident Texofab A Good Buy For Long Term?
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Trident Texofab Share Price Target For 2024
- 1.1.1: Trident Texofab Share Price Target Table For 2024
- 1.1.2: Summary: Trident Texofab Share Price Prediction For 2024
- 1.2: Trident Texofab Share Price Target For 2025
- 1.2.1: Trident Texofab Share Price Target Table For 2025
- 1.2.2: Summary: Trident Texofab Share Price Prediction For 2025
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Trident Texofab Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 2.2: Trident Texofab Share Price Target Table From 2024, 2025, 2026 to 2039
- 3: Trident Texofab Past Performance
Trident Texofab Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 47.33 Crore | Market valuation of Trident Texofab's shares. |
| Revenue (TTM) | 96.35 Crore | Total revenue generated by Trident Texofab over the past twelve months. |
| Net Income (TTM) | +2.21 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 6.68% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 16.57% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | -0.84% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio | 2.57 | Company's total debt divided by total shareholder equity. |
| Total Debt | 40.62 Crore | Sum of Trident Texofab's current & long-term financial obligations. |
Is Trident Texofab A Good Buy For Long Term?
Trident Texofab, a small-cap stock with a market cap of ₹48.73 crore, has a mixed financial performance. While it generated revenue of ₹96.35 crore, its net profit of ₹2.21 crore in the last 12 months is modest. Additionally, the company's debt of ₹40.62 crore is a concern. The stock's negative returns across various time frames indicate a downward trend. Considering these factors, it may not be an ideal buy for long-term investment.
To predict the Trident Texofab's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Trident Texofab Share Price Target For 2024
The line chart displays the monthly closing prices of Trident Texofab with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Trident Texofab shares in 2024, see the table below.
Trident Texofab Share Price Target Table For 2024
| Trident Texofab's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 110.11 (+2.76%) | Price Action: 25 Oct 2024 High |
| 2024 Target 2 | 109.00 (+1.72%) | Price Action: 04 Nov 2024 High |
| 2024 Target 1 | 107.15 (0%) | Fibonacci Extension Level 199% |
| Current Price | 107.15 | Trident Texofab's 1 share price as of Thu 21 Nov 2024 |
| Stop Loss 1 | 107.15 (0%) | Fibonacci Retracement Extended 82.6% |
| Stop Loss 2 | 105.90 (-1.17%) | Price Action: Oct 2024 Low |
| Stop Loss 3 | 103.99 (-2.95%) | Price Action: Chart |
Summary: Trident Texofab Share Price Prediction For 2024
In summary, Trident Texofab has surged by ₹43.86, achieving a notable +69.30% increase from 1st January 2024 to 21 Nov 2024. Our analysis of Trident Texofab for 2024 predicts an additional rise of 0% to 2.76% by the end of 2024 with three potential targets T1: 107.15, T2: 109.00, T3: 110.11. Stop Loss at SL1: 107.15, SL2: 105.90, SL3: 103.99.
Trident Texofab has a 52-week high of ₹121.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹36.15, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Trident Texofab.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Trident Texofab Share Price Target For 2025
The line chart displays the monthly closing prices of Trident Texofab with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Trident Texofab shares in 2025, see the table below.
Trident Texofab Share Price Target Table For 2025
| Trident Texofab's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 153.34 (+43.1%) | Fibonacci Extension Level 171.8% |
| 2025 Target 2 | 149.93 (+39.92%) | Price Action: Chart |
| 2025 Target 1 | 148.45 (+38.54%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 107.15 | Trident Texofab's 1 share price as of Thu 21 Nov 2024 |
| Stop Loss 1 | 97.20 (-9.29%) | Price Action: Jul 2022 Low |
| Stop Loss 2 | 95.15 (-11.2%) | Price Action: Jan 2023 High |
| Stop Loss 3 | 93.44 (-12.8%) | Price Action: Chart |
Summary: Trident Texofab Share Price Prediction For 2025
In summary, Trident Texofab has surged by ₹43.86, achieving a notable +69.30% increase from 1st January 2024 to 21 Nov 2024. Our analysis of Trident Texofab for 2025 predicts an additional rise of 38.54% to 43.1% by the end of 2025 with three potential targets T1: 148.45, T2: 149.93, T3: 153.34. Stop Loss at SL1: 97.20, SL2: 95.15, SL3: 93.44.
Trident Texofab has a All-Time high of ₹206.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹36.15, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Trident Texofab, we have created a specific page for that check here: Trident Texofab Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Trident Texofab Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Trident Texofab share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 19.45% over the next 15 years.
For complete year by year Trident Texofab long term share price target from 2024, 2025 to 2039 check the below table.
Trident Texofab Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Trident Texofab Target | YoY Change % |
|---|---|---|
| 2024 | ₹107.15 | [Current Price] |
| 2024 | ₹92.88 | -13.32% |
| 2025 | ₹179.74 | 93.51% |
| 2026 | ₹222.9 | 24.01% |
| 2027 | ₹273.22 | 22.57% |
| 2028 | ₹357.99 | 31.02% |
| 2029 | ₹424.98 | 18.71% |
| 2030 | ₹554.45 | 30.46% |
| 2031 | ₹550.85 | -0.65% |
| 2032 | ₹583.79 | 5.98% |
| 2033 | ₹689.56 | 18.11% |
| 2034 | ₹757.08 | 9.79% |
| 2035 | ₹929.16 | 22.72% |
| 2036 | ₹878.79 | -5.43% |
| 2037 | ₹894.39 | 1.77% |
| 2038 | ₹1,021.13 | 14.17% |
| 2039 | ₹1,117.83 | 9.46% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Trident Texofab Past Performance
- In 2017, Trident Texofab opening price was ₹32
- As of Thu 21 Nov 2024 the price stands at ₹107.15.
- This represents a Compound Annual Growth Rate (CAGR) of 16.31%.
- In 7 years, an investment of 10,000 would have become ₹33,484.37.
As we wrap up, we hope you like our study on Trident Texofab share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
